Fig. 4From: Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplantGVHD, failure-free survival of two cohorts: HID, 1-year GFFS of 80.8% ± 4.2%; MRD 1-year GFFS of 88.4% ± 3.9% (P = 0.282)Back to article page